Pages that link to "Q35065639"
Jump to navigation
Jump to search
The following pages link to Glucotoxicity and beta-cell failure in type 2 diabetes mellitus (Q35065639):
Displaying 50 items.
- Loss of sugar detection by GLUT2 affects glucose homeostasis in mice (Q21092229) (← links)
- RETRACTED: Transcription factor 7-like 2 regulates beta-cell survival and function in human pancreatic islets (Q24302717) (← links)
- Protein Modifications as Manifestations of Hyperglycemic Glucotoxicity in Diabetes and Its Complications (Q26752842) (← links)
- Hyperglycemic Stress and Carbon Stress in Diabetic Glucotoxicity (Q26773988) (← links)
- Sources and implications of NADH/NAD(+) redox imbalance in diabetes and its complications (Q28076120) (← links)
- Islet Hypersensitivity to Glucose Is Associated With Disrupted Oscillations and Increased Impact of Proinflammatory Cytokines in Islets From Diabetes-Prone Male Mice (Q30277210) (← links)
- Stress-induced dissociations between intracellular calcium signaling and insulin secretion in pancreatic islets (Q30300205) (← links)
- T-cadherin (Cdh13) in association with pancreatic β-cell granules contributes to second phase insulin secretion (Q30513489) (← links)
- β-cell mass in people with type 2 diabetes (Q33558395) (← links)
- Lack of TXNIP protects against mitochondria-mediated apoptosis but not against fatty acid-induced ER stress-mediated beta-cell death (Q33604522) (← links)
- Protective effect of quercetin on the morphology of pancreatic beta-cells of streptozotocin-treated diabetic rats (Q33630001) (← links)
- Mesenchymal stem cells derived from bone marrow of diabetic patients portrait unique markers influenced by the diabetic microenvironment (Q33718101) (← links)
- Metabolic and Biochemical Stressors in Diabetic Cardiomyopathy (Q33740554) (← links)
- Postnatal development of numbers and mean sizes of pancreatic islets and beta-cells in healthy mice and GIPR(dn) transgenic diabetic mice (Q33983473) (← links)
- SGLT2 inhibition--a novel strategy for diabetes treatment (Q34117872) (← links)
- Antioxidant rich grape pomace extract suppresses postprandial hyperglycemia in diabetic mice by specifically inhibiting alpha-glucosidase (Q34128738) (← links)
- The possible role of epigenetics in gestational diabetes: cause, consequence, or both (Q34261542) (← links)
- New onset of diabetes after transplantation - an overview of epidemiology, mechanism of development and diagnosis (Q34382115) (← links)
- Maternal obesity in ewes results in reduced fetal pancreatic β-cell numbers in late gestation and decreased circulating insulin concentration at term. (Q34433830) (← links)
- Pioglitazone for the treatment of type 2 diabetes in patients inadequately controlled on insulin (Q34620604) (← links)
- Cathepsin inhibition-induced lysosomal dysfunction enhances pancreatic beta-cell apoptosis in high glucose (Q35019204) (← links)
- Geniposide regulates glucose-stimulated insulin secretion possibly through controlling glucose metabolism in INS-1 cells (Q35027910) (← links)
- Can Tea Extracts Exert a Protective Effect Against Diabetes by Reducing Oxidative Stress and Decreasing Glucotoxicity in Pancreatic β-Cells? (Q35126831) (← links)
- Optimal candidates for the switch from glimepiride to sitagliptin to reduce hypoglycemia in patients with type 2 diabetes mellitus. (Q35260937) (← links)
- Glucolipotoxicity in Pancreatic β-Cells (Q35564053) (← links)
- The role of sulphonylureas in the management of type 2 diabetes mellitus (Q35807254) (← links)
- SGLT-2 Inhibitors: A New Mechanism for Glycemic Control (Q35906490) (← links)
- A simple matter of life and death-the trials of postnatal Beta-cell mass regulation (Q35942505) (← links)
- Regulation of pancreatic beta-cell mass (Q36267776) (← links)
- Thioredoxin-interacting protein: a critical link between glucose toxicity and beta-cell apoptosis (Q36745735) (← links)
- Small molecule kaempferol modulates PDX-1 protein expression and subsequently promotes pancreatic β-cell survival and function via CREB. (Q36846424) (← links)
- Management of type 2 diabetes mellitus associated with pituitary gigantism. (Q36880794) (← links)
- Beta-cell failure in type 2 diabetes mellitus (Q37215420) (← links)
- Beta-cell apoptosis in type 2 diabetes: quantitative and functional consequences. (Q37221767) (← links)
- Rhein protects pancreatic β-cells from dynamin-related protein-1-mediated mitochondrial fission and cell apoptosis under hyperglycemia (Q37251144) (← links)
- Determining the relationship between dietary carbohydrate intake and insulin resistance (Q37350049) (← links)
- Sodium Glucose Co-transporter Type 2 (SGLT2) Inhibitors: Targeting the Kidney to Improve Glycemic Control in Diabetes Mellitus (Q37468412) (← links)
- Glucose regulation of β‐cell stress in type 2 diabetes (Q37804457) (← links)
- AMP-activated protein kinase and metabolic control (Q37864217) (← links)
- Mathematical model for glucose regulation in the whole-body system (Q38011989) (← links)
- SGLT2 inhibitors: a promising new therapeutic option for treatment of type 2 diabetes mellitus (Q38077305) (← links)
- Geniposide protects pancreatic β cells from high glucose-mediated injury by activation of AMP-activated protein kinase (Q38714524) (← links)
- Evogliptin: a new dipeptidyl peptidase inhibitor for the treatment of type 2 diabetes (Q38828606) (← links)
- Omarigliptin for the treatment of type 2 diabetes (Q38884175) (← links)
- Increased hexosamine biosynthetic pathway flux dedifferentiates INS-1E cells and murine islets by an extracellular signal-regulated kinase (ERK)1/2-mediated signal transmission pathway. (Q39456743) (← links)
- Effects of glucokinase activators GKA50 and LY2121260 on proliferation and apoptosis in pancreatic INS-1 beta cells (Q39819012) (← links)
- Insulin counteracts glucotoxic effects by suppressing thioredoxin-interacting protein production in INS-1E beta cells and in Psammomys obesus pancreatic islets (Q39884233) (← links)
- IGF-1 protects against dexamethasone-induced cell death in insulin secreting INS-1 cells independent of AKT/PKB phosphorylation (Q39985793) (← links)
- Stevioside improves pancreatic beta-cell function during glucotoxicity via regulation of acetyl-CoA carboxylase (Q40162688) (← links)
- Prolonged exposure to homocysteine results in diminished but reversible pancreatic beta-cell responsiveness to insulinotropic agents (Q40211094) (← links)